FDA Approves Emergency Contraceptive Drug ella™
Physicians now have another emergency contraceptive option to offer their female patients. The U.S. Food and Drug Administration (FDA) approved ella™ Aug. 13.
Ella (ulipristal acetate) is a progesterone agonist/antagonist emergency contraceptive intended for women to prevent pregnancy when taken within 120 hours after a contraceptive failure or unprotected sexual intercourse. Currently available over-the-counter levonorgestrel-based emergency contraceptives are indicated for use within 72 hours.
The prescription-only drug, manufactured by Watson Pharmaceuticals, Morristown, N.J., comes in 30 mg tablet form.
General billing guidelines instruct providers to indicate Family Planning ICD-9-CM code V25.03 Encounter for emergency contraceptive counseling and prescription in addition to the appropriate Evaluation and Management (E/M) CPT® code. Check with your insurance carrier for specific billing instructions, however.
For more information about ella™, read the FDA press release.